Patients with exon 19 deletion were associated with longer progression-free survival compared to those with L858R mutation after first-line EGFR-TKIs for advanced non-small cell lung cancer: a meta-analysis - Zhang, Y; Sheng, J; Kang, S (PLoS One, 2014)
, et al.